Walleye Capital’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-16,455
| Closed | -$467K | – | 2990 |
|
|
2023
Q1 | $467K | Buy |
16,455
+5,623
| +52% | +$160K | 0.01% | 1023 |
|
|
2022
Q4 | $317K | Buy |
+10,832
| New | +$317K | 0.01% | 1175 |
|
|
2022
Q2 | – | Sell |
-8,576
| Closed | -$424K | – | 2718 |
|
|
2022
Q1 | $424K | Buy |
+8,576
| New | +$424K | 0.01% | 1064 |
|
|
2020
Q1 | – | Sell |
-224
| Closed | -$13K | – | 1019 |
|
|
2019
Q4 | $13K | Sell |
224
-736
| -77% | -$42.7K | ﹤0.01% | 587 |
|
|
2019
Q3 | $54K | Buy |
960
+516
| +116% | +$29K | ﹤0.01% | 346 |
|
|
2019
Q2 | $25K | Buy |
444
+344
| +344% | +$19.4K | ﹤0.01% | 379 |
|
|
2019
Q1 | $5K | Buy |
+100
| New | +$5K | ﹤0.01% | 351 |
|